Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells
Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cells
复制标题
DOI:
10.1016/s0014-2999(01)00858-5
复制
发表时间:
2001-03-23
影响因子:
5
通讯作者:
Peters, GJ
中科院分区:
文献类型:
--
作者:
Bergman, AM;Pinedo, HM;Peters, GJ
Gemcitabine is phosphorylated by deoxycytidine kinase and thymidine kinase 2 and during S-phase incorporated into DNA. The steroids cortisol and dexamethasone, which regulate cell proliferation and gene expression, are pumped out of the cell by the membrane efflux pumps P-glycoprotein and multidrug resistance-associated protein (MRP), which are blocked by verapamil. In parental non-small cell lung cancer (NSCLC) cells (SW1573), 5 muM cortisol and 100 nM dexamethasone decreased sensitivity to gemcitabine. However, bath cortisol and dexamethasone only decreased sensitivity with verapamil in MRP (2R120) and P-glycoprotein (2R160) overexpressing variants. Cortisol decreased deoxycytidine kinase activity in SW1573 cells and cortisol with verapamil in 2R120 and 2R160 cells. Dexamethasone with verapamil decreased deoxycytidine kinase activity in 2R160. Cortisol decreased thymidine kinase 2 activity in 2R120 and 2R160 cells. Dexamethasone decreased thymidine kinase 2 activity in SW1573, 2R120 and 2R160 cells. In conclusion, since dexamethasone is frequently used to treat side effects of oncolytic therapy, a decrease of sensitivity to gemcitabine by steroids might be clinically relevant. (C) 2001 Elsevier Science B.V. All rights reserved.